-
Strategic Alliances and Technology Integration in the Evolving Biopharma Landscape
02 Oct 2025 02:09 GMT
…
Who Should Attend:
Biotechnology and Pharmaceutical Technology Experts
Biopharmaceutical Business Development … at MD Anderson, Teva Pharmaceuticals, CoGenesys, and Human Genome Sciences.
Sigma Mostafa, PhD
Chief …
-
Maze Therapeutics Appoints Misbah Tahir as Chief Financial Officer
02 Sep 2025 11:00 GMT
… Company), Onyx Pharmaceuticals, Inc. (acquired by Amgen Inc.), and Human Genome Sciences Inc. (acquired …
-
Human Genome Sciences Raises $100 Million from Private Offering
21 Sep 2019 11:05 GMT
… adjustment in certain circumstances.
Human Genome Sciences plans to use the … .
General corporate purposes.
Human Genome Sciences develops pharmaceutical products to predict, prevent … William A. Haseltine, CEO, Human Genome Sciences, 9410 Key West Ave., …
-
Rectify Pharmaceuticals Appoints Sachiyo Minegishi as Chief Operating Officer
25 Apr 2023 11:15 GMT
Rectify Pharmaceuticals, Inc., (“Rectify”) a biotechnology company … held leadership roles at Aegerion Pharmaceuticals, Human Genome Sciences, Genzyme, and Amgen. She began … into the clinic.”
About Rectify Pharmaceuticals, Inc. (“Rectify”)
Rectify is …
-
InterAx Biotech Announces the Appointment of Seasoned Pharmaceutical Executive, Dr. Christopher Prior, as CEO and Reports Recent Drug Discovery Highlights
25 Jan 2023 01:47 GMT
… at Aventis (now Sanofi), Pfizer, Human Genome Sciences (now GSK) and Biogen. Dr … -Announces-the-Appointment-of-Seasoned-Pharmaceutical-Executive-Dr-Christopher-Prior-as …
-
Chronic Inflammatory Demyelinating Polyneuropathy Market Report 2025 | Grifols, Kedrion Biopharma, Octapharma, AstraZeneca's Alexion, Argenx, Horizon Therapeutics, and Biogen Lead Innovations - ResearchAndMarkets.com
20 Aug 2025 18:12 GMT
… Pharmaceuticals, Inc.)
Argenx SE
Amgen (Horizon Therapeutics plc)
Biogen Inc.
GlaxoSmithKline (Human Genome Sciences … , Inc.)
Pfizer Inc.
Takeda Pharmaceutical Company … KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH NEUROLOGY
SOURCE …
-
Chronic Inflammatory Demyelinating Polyneuropathy Market Report 2025 Distribution Channel, Route Of Administration, And Region Analysis And Forecast To 2035
11 Aug 2025 11:44 GMT
… , Octapharma, Alexion Pharmaceuticals (now part of … Pharmaceuticals, Inc.) Argenx SE Amgen (Horizon Therapeutics plc) Biogen Inc. GlaxoSmithKline (Human Genome Sciences … , Inc.) Pfizer Inc. Takeda Pharmaceutical Company …
-
Veranova appoints Thomas Rohrer as vice president of bioconjugation
30 Jul 2025 11:21 GMT
… and complex API for the pharmaceutical and biotech sectors, announced the … development at Human Genome Sciences (later acquired by GSK), Otsuka America Pharmaceutical, Guidepoint Global …
-
Flashpoint Therapeutics Appoints Barry Labinger as CEO
29 Jul 2025 20:22 GMT
… served as CEO at Checkmate Pharmaceuticals, where he led the company … his previous leadership positions at Human Genome Sciences, Bristol Myers Squibb, and Abbott …
-
Flashpoint Therapeutics Appoints Barry Labinger as Chief Executive Officer
28 Jul 2025 22:40 GMT
… positions, including those at Human Genome Sciences, Bristol Myers Squibb, … roles at Immunex, 3M Pharmaceuticals, Human Genome Sciences, Emergent BioSolutions, Bristol Myers … DEVICES NANOTECHNOLOGY BIOTECHNOLOGY HEALTH PHARMACEUTICAL SCIENCE ONCOLOGY
SOURCE: …
About
© 1995-2025